Aroa Biosurgery Limited (ASX:ARX)
0.4850
+0.0050 (1.04%)
Nov 17, 2026, 11:30 AM AEDT
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 167.76 million as of November 16, 2026. It is the 23,852nd most valuable company in the world and the 489th biggest in Australia. Its market cap has decreased by 32.47% in one year.
Market Cap
167.76M
Enterprise Value
150.48M
Revenue
86.47M
Global Rank
Country Rank
#489 Australia
PE Ratio
45.16
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 167.76M, a decrease of -58.59%. That is a compound annual growth rate of -13.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 167.76M | -34.29% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 611.40M |
| Imricor Medical Systems | 469.84M |
| EMVision Medical Devices | 132.46M |
| EBR Systems | 131.05M |
| SomnoMed | 70.33M |
| Lumos Diagnostics Holdings | 68.02M |
| Epiminder | 59.58M |
| Cyclopharm | 57.84M |